Kekitiinwa AR - Search Results

1

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.

Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team. Turkova A, et al. Among authors: kekitiinwa ar. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793. N Engl J Med. 2021. PMID: 34965338 Free PMC article. Clinical Trial.

2

Bacteraemia in severely malnourished children in an HIV-endemic setting.

Babirekere-Iriso E, Musoke P, Kekitiinwa A. Babirekere-Iriso E, et al. Ann Trop Paediatr. 2006 Dec;26(4):319-28. doi: 10.1179/146532806X152845. Ann Trop Paediatr. 2006. PMID: 17132297

3

The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.

Namukwaya Z, Mudiope P, Kekitiinwa A, Musoke P, Matovu J, Kayma S, Salmond W, Bitarakwate E, Mubiru M, Maganda A, Galla M, Byamugisha J, Fowler MG. Namukwaya Z, et al. J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):69-75. doi: 10.1097/QAI.0b013e3181fdb4a8. J Acquir Immune Defic Syndr. 2011. PMID: 21099692

4

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.

Musiime V, Kendall L, Bakeera-Kitaka S, Snowden WB, Odongo F, Thomason M, Musoke P, Adkison K, Burger D, Mugyenyi P, Kekitiinwa A, Gibb DM, Walker AS; ARROW Trial team. Musiime V, et al. Antivir Ther. 2010;15(8):1115-24. doi: 10.3851/IMP1695. Antivir Ther. 2010. PMID: 21149918 Clinical Trial.

5

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.

Nahirya-Ntege P, Musiime V, Naidoo B, Bakeera-Kitaka S, Nathoo K, Munderi P, Mugyenyi P, Kekitiinwa A, Bwakura-Dangarembizi MF, Crawley J; ARROW Trial Team. Nahirya-Ntege P, et al. Pediatr Infect Dis J. 2011 Jun;30(6):535-7. doi: 10.1097/INF.0b013e3182076864. Pediatr Infect Dis J. 2011. PMID: 21164384 Clinical Trial.

6

Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy.

Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, Nathoo KJ, Karungi C, Lutaakome J, Kekitiinwa A, Gibb DM. Prendergast A, et al. AIDS. 2011 Apr 24;25(7):951-6. doi: 10.1097/QAD.0b013e328345e56b. AIDS. 2011. PMID: 21487251 Clinical Trial.

7

Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.

Tukei VJ, Asiimwe A, Maganda A, Atugonza R, Sebuliba I, Bakeera-Kitaka S, Musoke P, Kalyesubula I, Kekitiinwa A. Tukei VJ, et al. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):274-80. doi: 10.1097/QAI.0b013e3182423668. J Acquir Immune Defic Syndr. 2012. PMID: 22126740

8

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.

Kasirye P, Kendall L, Adkison KK, Tumusiime C, Ssenyonga M, Bakeera-Kitaka S, Nahirya-Ntege P, Mhute T, Kekitiinwa A, Snowden W, Burger DM, Gibb DM, Walker AS; ARROW Trial Team. Kasirye P, et al. Clin Pharmacol Ther. 2012 Feb;91(2):272-80. doi: 10.1038/clpt.2011.225. Epub 2011 Dec 21. Clin Pharmacol Ther. 2012. PMID: 22190066

9

Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa.

Nahirya-Ntege P, Cook A, Vhembo T, Opilo W, Namuddu R, Katuramu R, Tezikyabbiri J, Naidoo-James B, Gibb D; ARROW Trial Team. Nahirya-Ntege P, et al. PLoS One. 2012;7(5):e36186. doi: 10.1371/journal.pone.0036186. Epub 2012 May 2. PLoS One. 2012. PMID: 22567139 Free PMC article.

10

Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.

Kekitiinwa A, Asiimwe AR, Kasirye P, Korutaro V, Kitaka S, Maganda A, Madalon M, Graziano FM. Kekitiinwa A, et al. Pediatr Infect Dis J. 2012 Aug;31(8):e117-25. doi: 10.1097/INF.0b013e31825cb9d6. Pediatr Infect Dis J. 2012. PMID: 22581223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page